Prediction of miscarriage and stillbirth at 11–13 weeks and the contribution of chorionic villus sampling
Open Access
- 5 January 2011
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 31 (1), 38-45
- https://doi.org/10.1002/pd.2644
Abstract
Objectives To derive models for estimating risk of miscarriage and stillbirth from maternal characteristics and findings of first-trimester screening for aneuploidies and to define the procedure-related risk of chorionic villus sampling (CVS) after adjusting for these factors. Method We examined 33 856 singleton pregnancies at 11+0 to 13+6 weeks, and in 2396 CVS was carried out. Logistic regression analysis was used to examine the factors contributing to miscarriage and stillbirth. Results There were 33 310 (98.4%) livebirths, 404 (1.2%) miscarriages and 142 (0.4%) stillbirths. Models combining maternal characteristics, nuchal translucency, pregnancy-associated plasma protein-A (PAPP-A) and flow in the ductus venosus detected 36.9% of miscarriages and 35.2% of stillbirths, at a 10% false-positive rate. The risk of miscarriage and stillbirth increased with maternal age and weight, in women of African racial origin, in those with previous miscarriages or stillbirths and in those with low serum PAPP-A and reversed A-wave in the ductus venosus. The risk of miscarriage increased in women with pre-existing diabetes mellitus, in those conceiving on ovulation-induction drugs and in those with high fetal nuchal translucency, and the risk of stillbirth increased in women with chronic hypertension and in cigarette smokers. The expected number of miscarriages and stillbirths in the CVS group and the models derived from the non-CVS group were 45 (95% prediction intervals 32–58) and 18 (95% prediction intervals 9–26), respectively. These expected numbers were not significantly different from the observed 44 and 15 cases (p = 0.881 and 0.480), respectively. Conclusion A high proportion of fetal losses can be predicted at 11 to 13 weeks. A model for such predictions can be used to assess the procedure-related risks from CVS. Copyright © 2011 John Wiley & Sons, Ltd.Funding Information
- Fetal Medicine Foundation
This publication has 34 references indexed in Scilit:
- Reduced birthweight in short or primiparous mothers: physiological or pathological?BJOG: An International Journal of Obstetrics and Gynaecology, 2010
- Racial disparities in stillbirth risk across gestation in the United StatesAmerican Journal of Obstetrics and Gynecology, 2009
- Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markersAmerican Journal of Obstetrics and Gynecology, 2008
- The influence of maternal smoking habits on the risk of subsequent stillbirth: is there a causal relation?BJOG: An International Journal of Obstetrics and Gynaecology, 2007
- First‐trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal deathUltrasound in Obstetrics & Gynecology, 2006
- Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based studyBMJ, 2006
- Etiology and prevention of stillbirthAmerican Journal of Obstetrics and Gynecology, 2005
- Randomised study of risk of fetal loss related to early amniocentesis versus chorionic villus samplingThe Lancet, 1997
- Incidence of Spontaneous Abortion among Normal Women and Insulin-Dependent Diabetic Women Whose Pregnancies Were Identified within 21 Days of ConceptionThe New England Journal of Medicine, 1988
- RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMENThe Lancet, 1986